Table 4 Quality assessment of clinical trials by Jadad score
Author, year | Type | Randomization | Concealment of allocation | Double blinding | Withdrawals and dropouts | Jaded score |
|---|---|---|---|---|---|---|
Packham et al., 2016 | Multicenter, randomized, double-blind, dose-escalating, sequential, placebo-controlled trial | An Interactive Voice Response System/Interactive Web Response System (IVRS/IWRS) was accessed to randomize eligible patients. | All infusions were prepared by an unblinded pharmacist at the phase 1 unit who provided to the blinded clinical staff visually identical infusion products comprising rexlemestrocel-L or saline suspended in 100 mL normal saline. | Patients, investigators, and the sponsor were blinded to the treatment allocation through the entire 60-week study. | Yes | 7 |